Health Catalyst Inc reports results for the quarter ended March 31 - Earnings Summary

• Health Catalyst Inc HCAT.OQ reported quarterly adjusted earnings of 1 cent​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 5 cents. The mean expectation of twelve analysts for the quarter was for breakeven results per share. Wall Street expected results to range from -3 cents to 4 cents per share.

• Revenue rose 6.3% to $79.41 million from a year ago; analysts expected $79.17 million.

• Health Catalyst Inc's reported EPS for the quarter was a loss of 35 cents​.

• The company reported a quarterly loss of $23.74 million.

• Health Catalyst Inc shares had fallen by 10.2% this quarter and lost 42.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 97.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the software peer group is also "buy"

• Wall Street's median 12-month price target for Health Catalyst Inc is $7.25

This summary was machine generated from LSEG data May 7 at 09:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)